MedTrace Logo

Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

NCT03847220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2023-03-06

No results posted yet for this study

Summary

Epidemiological, prospective and multicenter study to evaluate the utility of the BOMET-QoL questionnaire in patients with breast cancer (BC) and bone metastases (BM).

Conditions

  • Breast Carcinoma Metastatic to the Bone

Interventions

DIAGNOSTIC_TEST

BOMET-QoL questionnaire

study to evaluate the utility of the BOMET-QoL questionnaire in patients with BC and BM

Sponsors & Collaborators

Principal Investigators

  • Study Director · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-23
Primary Completion
2010-05-20
Completion
2012-07-07

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847220 on ClinicalTrials.gov